Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Second Quarter 2026 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...
Earnings call Atea Pharmaceuticals reported positive phase III C-BEYOND results for bemnifosbuvir in HCV, achieving non-inferiority to standard of care and supporting a best-in-class profile. Cash and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results